Eva Teng, Marcelle Pignanelli, Faiza Hammad, David Wisa
The Effect of COVID-19 on Diabetic Ketoacidosis Management and Outcomes: The Experience of Two NYC Hospitals
L. Danielson, A. Allemyar, M. Pignanelli, J. Monye, R. Pinsker, B. Patel
The COVID19 Experience: Preliminary Results in 1651 Patients at Two Multi-Ethnic Community Hospitals in NYC
J. Shakil, F. Bagheri, J. Robitsek, V. Zafonte, D. M. Wisa, M. Walczyszyn, K. Gafoor, A. Solinas, R. Mendelson
Coinfected with SARS-CoV-2 and Influenza B: A 2-Week-Old Presenting with Apnea
R. Maddali, J. Raynor, K. Cervellione, L. Lew
A Case of COVID19 Followed by PCP Pneumonia in an Immunocompromised Host
L. Ramdhanie, K. Gafoor, S. Chauhan, K. Cervellione
Tocilizumab Has Limited Clinical Utility for COVID19 in Two Multiethnic Community Hospitals
K. Cervellione, G. Dadi, N. Hameedi, M. Pignanelli, B. Kuriakose, V. Zafonte, T. Ullah, J. Robitsek, G. Pena Fatule, H. Patel, D. M. Wisa, K. Gafoor, M. Walczyszyn, J. Shakil, F. Bagheri, A. Solinas, R. Mendelson
New Onset Granulomatosis with Polyangiitis Associated with COVID-19
Moshe Y. Bressler, Naeha Pathak, Kelly Cervellione, Farshad Bagheri, Edward Epstein, Adnan Mir, and Rebecca Tamez
Development of Bloodstream Infection After Tocilizumab Treatment for SARS-CoV-2 Cytokine Storm
Zafonte, Veronica; Pena, Grace Martinez; Patel, Harsh; Shinn, Grace; Jagata, Ravali; Cervellione, Kelly; Bosco, Michael; Wisa, David; Walczyszyn, Maciej; Shakil, Javeria; Patel, Mahendra; Bagheri, Farshad; Gafoor, Khalid
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
